Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)

Although the evidence for the benefit of adding temozolomide (TMZ) to radiotherapy (RT) is limited to glioblastoma patients, there is currently a trend toward treating anaplastic astrocytomas (AAs) with combined RT + TMZ. The aim of the present study was to describe the patterns of care of patients...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Scoccianti, Silvia, Magrini, Stefano Maria, Ricardi, Umberto, Detti, Beatrice, Krengli, Marco, Parisi, Salvatore, Bertoni, Filippo, Sotti, Guido, Cipressi, Samantha, Tombolini, Vincenzo, Dall'Oglio, Stefano, Lioce, Marco, Saieva, Calogero, Buglione, Michela, Mantovani, Cristina, Rubino, Giovanni, Muto, Paolo, Fusco, Vincenzo, Fariselli, Laura, de Renzis, Costantino, Masini, Laura, Santoni, Riccardo, Pirtoli, Luigi, Biti, Giampaolo
Format: Artigo
Język:Inglês
Wydane: Oxford University Press 2012
Hasła przedmiotowe:
Clinical Investigations
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3367850/
https://ncbi.nlm.nih.gov/pubmed/22539339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos081
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy